Fundació de Recerca Sant Joan de Déu’s Post

🌟 Exciting News 🔬Catalonia is leading a €23 million European project for personalized medicine and advanced therapies! 🎯 The #PRECISEU project involves 25 partners from 12 European regions. By sharing best practices and solutions across regions, the goal is to advance proactive, personalized, and patient-centered healthcare. 🌍 Catalonia is the region with the highest number of participants in the project, with the Department of Health, ACCIÓ-Catalonia Trade & Investment, the Barcelona Supercomputing Center, AstraZeneca, and Biocat, BioRegion of Catalonia, who is the project coordinator. 🗣 According to Pere Aragonès, President of the Government of Catalonia, "Catalonia is consolidating as one of the hubs of reference in health innovation on the European continent." Learn more 👉 https://lnkd.in/dYMnqX8i #HealthInnovation #PRECISEU #Catalonia

Welcome to our new members 👋🏽   These companies join more than 3,000 organisations as members of AusBiotech, Australia’s national peak body for the life sciences. Our members are a diverse, nationwide community of life science companies, senior leaders, researchers and experts all focused on developing innovative breakthroughs that improve health outcomes. We look forward to working with you as we collectively build Australia’s biotechnology ecosystem.   Read more about our new members and what they do below.   ➡️ Cytiva is a global provider of technologies and services that advance the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva has nearly 7,000 employees and operations in 40 countries. ➡️ Increment4 Pty Ltd is a consultancy providing services in ATMP’s, medical devices, pharma digitalisation, operational excellence, regulatory consulting, and due diligence assessments. ➡️ Resonance Health Ltd is an Australian medtech company that specialises in the development and commercialisation of non-invasive medical imaging analysis. Its portfolio includes Core Lab and AI powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. ➡️ Respiri Limited is an ASX-listed company developing SaaS diagnostic and RPM solutions to support respiratory health management. Its technology detects wheeze, a typical symptom of asthma, chronic obstructive pulmonary disease and respiratory disease, to provide an objective measure of airway limitation. ➡️Viatris is a global healthcare company that aims to bridge the traditional divide between generics and brands, combining the best of both across a broad range of therapeutic areas to more holistically address healthcare needs globally. ➡️Area 53, Wentworth Capital – Area 53 is a new venture of Wentworth Capital, a real estate private equity firm focused on thematic based investing and investments into special situations. Become a member of AusBiotech to strengthen your connections in the Australian life sciences industry, benefit from longstanding relationships across government, industry and academia, and shape advocacy efforts and help foster a sustainable and globally competitive sector. Find out more about member benefits here: https://lnkd.in/gDzXcq_g

Catalonia leads the PRECISEU project to promote personalized medicine - https://lnkd.in/dYU2reb7 - Catalonia leads PRECISEa European-wide macro-project to promote personalised medicine and advanced therapies. This initiative is among the five winning projects of Regional Innovation Valleys (RIV), within the European Innovation Ecosystems (EIE) programme. PRECISEU aims to accelerate the adoption of personalised medicine in

Catalonia leads the PRECISEU project to promote personalized medicine - https://lnkd.in/dJkv_wqj - Catalonia leads PRECISEa European-wide macro-project to promote personalised medicine and advanced therapies. This initiative is among the five winning projects of Regional Innovation Valleys (RIV), within the European Innovation Ecosystems (EIE) programme. PRECISEU aims to accelerate the adoption of personalised medicine in

Transforming Life Sciences: Key Highlights from Premier Industry Events in Q4 2023 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞 @ https://lnkd.in/ebs8A99H #lifesciences #healthcare #technology #marketresearch

The Weekly BHI E-Newsletter is live: 📈 TEDCO Invests in Linshom Medical, Inc.: Maryland's support for improved patient safety continues with a $400K investment in Linshom's innovative wearable sensor technology. Learn more about this vital investment here. 🧠 Gain Therapeutics: Phase 1 Clinical Trial Initiation: Gain Therapeutics kicks off the Multiple Ascending Dose (MAD) phase of its Phase 1 trial for GT-02287, a novel therapy targeting GBA1 Parkinson’s disease. Dive into the details of this promising development. 💡 ATCC and Tissue Dynamics Collaborate for Heart Health: A strategic partnership between ATCC and Tissue Dynamics aims to revolutionize cardiac safety testing with advanced cardiac organoid-based kits. Discover more about this groundbreaking collaboration. 👩🔬 BioBuzz's 10 Women Shaping the Life Sciences: In celebration of Women’s History Month, BioBuzz highlights 10 remarkable women making significant contributions to the BioHealth Capital Region's life sciences sector. 🚀 Rockville Economic Development, Inc. (REDI) BioBoost Series: REDI launches its inaugural BioBoost event, "The Future of Bio/Life Science Funding in 2024," offering industry professionals valuable insights into the latest investment trends and funding opportunities. 💊 The March-In Debate: Three Congressional Letters Signal Shift: Delve into the evolving discussion surrounding the Biden Administration's proposed march-in guidelines and their potential impact on American innovation. 🏢 Cartesian Therapeutics' New Headquarters: Cartesian Therapeutics relocates its corporate headquarters to Frederick, Maryland, unveiling a cutting-edge mRNA cell therapy manufacturing facility. Learn more about this milestone move. Visit the link to read all these stories and more. https://lnkd.in/ewY_hzfh

👀 Did you miss the roundtable "Catalonia Advanced Therapies Ecosystem: Building Europe’s Future in ATMPs" at #RESIEurope2024? You can watch the recording of the debate here 👇 ▶️ https://lnkd.in/dYUZ8Cq5 The panel discussion highlighted the key role Catalonia’s advanced therapies will play in innovation and clinical breakthroughs in Europe. As Robert Fabregat Fuentes (#Biocat's CEO) emphasized: Catalonia ranks 5th in Europe and 8th worldwide in participation in clinical trials of #ATMPs. Moreover, the #BioRegion stands out in the number of publications on advanced therapies. 🗣 Luis Pareras MD, PhD (Invivo Partners) pointed to the quality of Catalan research: "In the field of advanced therapies and synthetic #biology, we have some of the best scientists in Europe and the world." For the roundtable participants, the main challenges posed by advanced therapies include attracting qualified #talent and ensuring patients' access to therapies. 🗣 Fina Lladós Canela (Amgen España) highlighted the need to scale up therapy production and ensure patient access: "It makes no sense to invest and attract innovation if it does not reach patients." Similarly, Esteve Trias i Adroher (Leitat Technological Center) expressed that while Catalonia is strong at both the beginning and end of the chain, it is fundamental to 💬 "build this bridge between research and transfer." 🗣 For Silvia Martín Lluesma (Vall d'Hebron Institute of Oncology (VHIO)), what is crucial is that researchers, clinicians, and regulatory professionals work hand in hand in the development of advanced therapies. To address these and other challenges in advanced therapies, Antoni Matilla Dueñas (BIOINTAXIS) brought up the recent creation of the Advanced Therapies Network of Catalonia, coordinated by #Biocat. 👉 This network aims to promote #research, manufacturing, and development of #AdvancedTherapies to make them accessible to the public efficiently and sustainably. #RESIEUROPE #RESIBARCELONA #RESI #ATMPs #AdvancedTherapies Life Science Nation

How are advancements in biotechnology and data analytics changing healthcare by tailoring treatments to individual patient needs? Discover the impact of personalised medicine in our latest blog, “The Rise of Personalised Medicine and its Impact on Market Research.” Uncover the role of market research in the evolution, including: - Understanding patient needs and preferences - Assessing market potential - Overcoming adoption barriers - Enhancing education for patients and providers Read the full blog > https://hubs.ly/Q02B5-zC0 #PersonalisedMedicine #MarketResearch #PatientCare